|4Mar 25, 6:45 PM ET

FRY WILLIAM 4

4 · MYR GROUP INC. · Filed Mar 25, 2024

Insider Transaction Report

Form 4
Period: 2024-03-22
FRY WILLIAM
SVP, CLO and Secretary
Transactions
  • Exercise/Conversion

    RESTRICTED STOCK UNIT

    2024-03-23604605 total
    From: 2024-03-23Exp: 2024-03-23Common Stock (604 underlying)
  • Exercise/Conversion

    RESTRICTED STOCK UNIT

    2024-03-235491,099 total
    From: 2024-03-23Exp: 2024-03-23Common Stock (549 underlying)
  • Tax Payment

    Common Stock

    2024-03-23$172.52/sh265$45,71812,007 total
  • Exercise/Conversion

    Common Stock

    2024-03-23+60412,272 total
  • Exercise/Conversion

    Common Stock

    2024-03-23+54912,556 total
  • Tax Payment

    Common Stock

    2024-03-23$172.52/sh241$41,57712,315 total
  • Exercise/Conversion

    RESTRICTED STOCK UNIT

    2024-03-239040 total
    From: 2024-03-23Exp: 2024-03-23Common Stock (904 underlying)
  • Exercise/Conversion

    Common Stock

    2024-03-23+90412,064 total
  • Award

    RESTRICTED STOCK UNIT

    2024-03-22+1,0431,043 total
    Common Stock (1,043 underlying)
  • Tax Payment

    Common Stock

    2024-03-23$172.52/sh396$68,31811,668 total
Footnotes (3)
  • [F1]These Restricted Stock Units, which were awarded on March 23, 2021, 2022 and 2023 pursuant to the Issuer's 2017 Long-Term Incentive Plan, vest ratably over three years and were settled in shares of the Issuer's common stock on a one-for-one basis.
  • [F2]Represents shares of the Issuer's common stock withheld to satisfy tax withholding obligations in connection with the vesting of Restricted Stock Units granted pursuant to the Issuer's 2017 Long-Term Incentive Plan.
  • [F3]Each Restricted Stock Unit, awarded pursuant to the Issuer's 2017 Long-Term Incentive Plan, represents a contingent right to receive one share of the Issuer's common stock. The Restricted Stock Units vest ratably over three years beginning on the first anniversary of the grant date.

Documents

1 file
  • 4
    marketforms-65328.xmlPrimary

    PRIMARY DOCUMENT